← All trials
NCT03743896
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2016
- Primary completion
- Mar 10, 2017
- Completion date
- Mar 10, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Lynk Biotechnologies Pte LtdLead sponsor
- T&T Family Health Clinic and Surgery, SingaporeCollaborator
- T&T Family Health Clinic and Surgery, SingaporeOverall official - principal investigator
- Temasek Polytechnic School of Applied Science, SingaporeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.